@rheumjnl.bsky.social Rheumatology Advances in Practice:
Imaging of gout
(an area with lots of nuance)
very pretty images but also lots of great practical hints from Luqman Wali & Emma Rowbotham
Well worth checking out & it's open access: academic.oup.com/rheumap/arti...
@rheumjnl.bsky.social Rheumatology Advances in Practice:
Imaging of gout
(an area with lots of nuance)
very pretty images but also lots of great practical hints from Luqman Wali & Emma Rowbotham
Well worth checking out & it's open access: academic.oup.com/rheumap/arti...
PMR underserved by Rx, somehow steroid monotherapy accepted as okay
Why? We feel four main reasons:
- myth of self-resolution
- seemingly nebulous presentation
- inadequate pathophys insights
- societal inattention (esp ageism)
snips below but check out full article⬆️
PMR underserved by Rx, somehow steroid monotherapy accepted as okay
Why? We feel four main reasons:
- myth of self-resolution
- seemingly nebulous presentation
- inadequate pathophys insights
- societal inattention (esp ageism)
snips below but check out full article⬆️
@drceowen.bsky.social and I call out many reasons.
PMR is killing them softly, and will continue to do so if collectively we neglect it.
now out @thelancetrheum.bsky.social:
t.co/wMOy9ZEzw4
@drceowen.bsky.social and I call out many reasons.
PMR is killing them softly, and will continue to do so if collectively we neglect it.
now out @thelancetrheum.bsky.social:
t.co/wMOy9ZEzw4
“PMR dose steroids don’t really matter”
Errrrr…
(You wouldn’t accept this steroid exposure in any other disease. Never)
#EULAR2025 POS0139 @rheumnow.bsky.social
“PMR dose steroids don’t really matter”
Errrrr…
(You wouldn’t accept this steroid exposure in any other disease. Never)
#EULAR2025 POS0139 @rheumnow.bsky.social
If we don’t get in early with a right diagnosis (and maybe early steroid-sparing) then PMR patients deteriorate.
We shouldn’t let PMR be an end stage disease #EULAR2025 POS0136 @rheumnow.bsky.social
If we don’t get in early with a right diagnosis (and maybe early steroid-sparing) then PMR patients deteriorate.
We shouldn’t let PMR be an end stage disease #EULAR2025 POS0136 @rheumnow.bsky.social
In the secukinumab ph2 in GCA (TitAIN), patients with PMR did really well, seemingly outperforming steroid taper in the placebo arm. Real promise, will be great to see how the ph3 in PMR (REPLENISH) goes
OP0062 #EULAR2025 @rheumnow.bsky.social
In the secukinumab ph2 in GCA (TitAIN), patients with PMR did really well, seemingly outperforming steroid taper in the placebo arm. Real promise, will be great to see how the ph3 in PMR (REPLENISH) goes
OP0062 #EULAR2025 @rheumnow.bsky.social
This is exactly SELECT-GCA in the second 6mo. What happened?
upa skews better on serious infection, worse on HZ
JAKi might have infection risk, but not like steroids. OP0057 #EULAR2025 @rheumnow.bsky.social
This is exactly SELECT-GCA in the second 6mo. What happened?
upa skews better on serious infection, worse on HZ
JAKi might have infection risk, but not like steroids. OP0057 #EULAR2025 @rheumnow.bsky.social
Of course with the dynamic team of @synovialjoints @Yuz6Yusof @DrMiniDey @AurelieRheumo @AdelaCastro222 @JihaRheum @Nellziade and the one and only @Janetbirdope
Of course with the dynamic team of @synovialjoints @Yuz6Yusof @DrMiniDey @AurelieRheumo @AdelaCastro222 @JihaRheum @Nellziade and the one and only @Janetbirdope